New cell therapy tested for Tough-to-Treat blood cancer
NCT ID NCT04155749
Summary
This early-stage study is testing experimental cell therapies for people with advanced multiple myeloma that has stopped responding to standard treatments. The main goals are to check if the treatments are safe and to find the best dose for future studies. It will involve about 40 patients who have already tried several other therapies without success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED AND REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Cellular Therapeutics Facility, DCAM 0800A
Chicago, Illinois, 60637, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Froedtert Hospital/Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.